ATI-2173|HBV inhibitor|DC Chemicals

Cas No.:
Chemical Name:	ATI-2173
Synonyms:	ATI-2173;ATI 2173;ATI2173
SMILES:	CC1C(=O)NC(=O)N([C@@H]2[C@H](F)[C@@H](O)[C@H](CO[P@@H0](N[C@@H](C)C(=O)OC(C)C)(OC3=CC=CC=C3)=O)O2)C=1
Formula:	C₂₂H₂₉FN₃O₉P
M.Wt:	529.16
Purity:	>98%

MSDS

COA

Cat. No.	Product name	Field of application
DC53050	ATI-2173	ATI-2173 is a novel liver-targeted molecule designed to deliver the 5′-monophosphate of clevudine for the treatment of chronic hepatitis B infection.
DC72290	DVR-01	DVR-01 is a HBV inhibitor with EC50 values of 1.7 and 1.6 μM in AML12HBV10 and HepDES19 cells, respectively. DVR-01 shows antiviral activity against drug-resistant HBV mutants with EC50s of 2.403-3.273 μM. DVR-01 can be used for the research of HBV infection and related diseases.
DC47259	Inarigivir ammonium	Inarigivir (ORI-9020) ammonium is a dinucleotide antiviral drug which can significantly reduce liver HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir (ORI-9020) act as an RIG-I agonist to activate cellular innate immune responses.
DC11296	GLP-26	GLP-26 is a novel potent HBV capsid modulator that reduces secreted HBeAg in HepNTCPDL cells transfected with HBV wild type with EC50 of 0.7 uM.